Ziphius

Ziphius is a biotechnology company developing best-in-class vaccines and therapeutics based on its proprietary saRNA and carrier technology(LNP) platform to allow for a higher and prolonged protein/antigen expression at lower doses compared to conventional mRNA with reduced toxicity. Based in Ghent (Belgium) and New York (US) the company showcases strategic developments in infectious diseases, protein replacement therapies and a cutting-edge oncology program.